Advanced search
Publication Cover
Leukemia & Lymphoma Volume 60, 2019 - Issue 13
Submit an article Journal homepage
157
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

Common clonal origin of an EBV-positive diffuse large B cell lymphoma and a chronic myelomonocytic leukemia

Loïc VasseurHematology-Oncology Department, Centre Hospitalier de Versailles, Le Chesnay, France; ORCID Iconhttp://orcid.org/0000-0001-9065-0477
ORCID Icon,
Diane LaraHematology-Oncology Department, Centre Hospitalier de Versailles, Le Chesnay, France; ;Université Versailles-Saint-Quentin-en-Yvelines, Versailles, France;
,
Emmanuelle ClappierHematology Laboratory, Assistance Publique-Hopitaux de Paris, Saint-Louis Hospital, Paris, France; ;Université Paris 7 Diderot, Paris, France;
,
Quentin GillebertNuclear Medicine, André Mignot Hospital, Le Chesnay, France;
,
Claire GlaserPathology Departement, André Mignot Hospital, Le Chesnay, France;
,
Solene Houlle-CrepinPathology Departement, André Mignot Hospital, Le Chesnay, France;
,
Nicolas OrtonnePathology Departement, Henri Mondor Hospital, Créteil, France; ;Université Paris Est Créteil, Créteil, France
,
Elsa PoullotPathology Departement, Henri Mondor Hospital, Créteil, France;
,
Philippe RousselotHematology-Oncology Department, Centre Hospitalier de Versailles, Le Chesnay, France; ;Université Versailles-Saint-Quentin-en-Yvelines, Versailles, France;
&
Caroline BessonHematology-Oncology Department, Centre Hospitalier de Versailles, Le Chesnay, France; ;Université Versailles-Saint-Quentin-en-Yvelines, Versailles, France; Correspondence[email protected]
 show all
Pages 3327-3329 | Received 23 Feb 2019, Accepted 27 May 2019, Published online: 11 Jun 2019

References

  • El-Fattah MA. Second malignancies in survivors of chronic myelomonocytic leukemia: a U.S. population-based study. Leuk Lymphoma. 2017:58:1–7.
  • Menter T, Schlageter M, Bastian L, et al. Development of an Epstein–Barr virus-associated lymphoproliferative disorder in a patient treated with azacitidine for chronic myelomonocytic leukaemia. Hematol Oncol. 2014;32:47–51.
  • Saillard C, Guermouche H, Derrieux C, et al. Response to 5-azacytidine in a patient with TET2-mutated angioimmunoblastic T-cell lymphoma and chronic myelomonocytic leukaemia preceded by an EBV-positive large B-cell lymphoma. Hematol Oncol. 2017:35:864–868.
  • Sale S, Fumi M, Pancione Y, et al. The fortuitous diagnosis of Burkitt lymphoma in a patient with chronic myelomonocytic leukemia. Am J Hematol. 2016;91:443.
  • Asmar F, Punj V, Christensen J, et al. Genome-wide profiling identifies a DNA methylation signature that associates with TET2 mutations in diffuse large B-cell lymphoma. Haematologica. 2013;98:1912–1920.
  • Kubuki Y, Yamaji T, Hidaka T, et al. TET2 mutation in diffuse large B-cell lymphoma. J Clin Exp Hematop. 2017;56:145–149.
  • Mouly E, Ghamlouch H, Della-Valle V, et al. B-cell tumor development in Tet2-deficient mice. Blood Adv. 2018;2:703–714.
  • Batlle-López A, Cortiguera MG, Delgado MD. The epigenetic regulator CTCF modulates BCL6 in lymphoma. Oncoscience. 2015;2:783–784.
  • Pasqualucci L, Dalla-Favera R. Genetics of diffuse large B cell lymphoma. Blood. 2018:31:2307–2319.
  • Liu Y, Easton J, Shao Y, et al. The genomic landscape of pediatric and young adult t-lineage acute lymphoblastic leukemia. Nat Genet. 2017;49:1211–1218.
  • Cremona CA, Behrens A. ATM signalling and cancer. Oncogene. 2014;33:3351–3360.
  • Stein MK, Crawley M, Vick E, et al. Concomitant ATM mutations identified by next generation sequencing in a patient with new-onset acute myeloid leukemia following imatinib treatment for chronic myeloid leukemia. World J Oncol. 2018;9:66–67.
  • Couronné L, Bastard C, Bernard OA. TET2 and DNMT3A mutations in human T-cell lymphoma. N Engl J Med. 2012;366:95–96.
  • Lemonnier F, Dupuis J, Sujobert P, et al. Treatment with 5-azacytidine induces a sustained response in patients with angioimmunoblastic T-cell lymphoma. Blood. 2018;132:2305–2309.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.